FDA Approves Gene Therapy for Deafness
The FDA has approved the first gene therapy for a rare form of deafness, developed by Regeneron Pharmaceuticals. The treatment was successfully tested on a patient.
Advertisement: Article Inline
The FDA has approved the first gene therapy for a rare form of deafness, developed by Regeneron Pharmaceuticals. The treatment was successfully tested on a patient.